Latest Regulatory News

St George Mining has initiated a 10,000-metre drilling program at its Araxá Project in Brazil, aiming to significantly grow its already substantial rare earths and niobium resource. The campaign combines multiple drilling techniques alongside a high-resolution airborne magnetic survey to unlock further mineral potential.

Bastion Minerals has confirmed it is finalising a JORC Mineral Resource Estimate for its ICE Copper Gold Project, explaining recent sharp price and volume movements in its shares. The company plans to announce the estimate by June 10, 2025.

Resolution Minerals Ltd has had its trading suspension lifted immediately following the announcement of a material acquisition, signaling a pivotal moment for the exploration company.

North Stawell Minerals Ltd (ASX, NSM) is advancing its gold exploration ambitions with a $3.6 million equity raising aimed at funding key projects near the prolific Stawell Gold Mine in Victoria. The capital injection will support drilling and geological modelling to unlock new gold discoveries under a thin sediment cover.

Resolution Minerals Limited has secured the Horse Heaven Project in Idaho, adjacent to the major Stibnite Gold Project, aiming to address critical US antimony supply shortages with a planned 2025 drilling campaign.

Resolution Minerals Ltd has entered a binding agreement to acquire the Horse Heaven Project in Idaho, a promising antimony-gold-silver-tungsten asset adjacent to a major US mine, with drilling planned for 2025.

North Stawell Minerals has announced a combined $3.6 million capital raise through a placement and a pro-rata entitlement offer, aiming to bolster its exploration activities without materially altering company control.

Johns Lyng Group has received a conditional, non-binding acquisition proposal from Pacific Equity Partners, sparking a potential shift in ownership with key management poised to retain stakes. The company has granted exclusivity for due diligence, setting the stage for a possible binding offer.

PYC Therapeutics has secured Safety Review Committee approval to increase dosing in its clinical trial for a novel treatment targeting Autosomal Dominant Optic Atrophy, a rare blinding genetic disease. This milestone marks a significant step forward in the development of PYC-001, a first-in-class RNA therapy.

Olympio Metals has secured approvals to drill up to 38 holes totaling 10,000 meters at its Bousquet Gold Project in Quebec, aiming to unlock high-grade gold potential along the prolific Cadillac Break. Drilling is set to start imminently, targeting promising zones with historic intercepts.

BluGlass Limited has extended the closing date of its Share Purchase Plan to June 13, 2025, giving eligible shareholders more time to subscribe at a discounted price. The move aims to maximize participation ahead of a crucial shareholder vote.

Helia Group announces the departure of CEO Pauline Blight-Johnston after five years, appointing CFO Michael Cant as interim CEO amid evolving market conditions. The leadership change signals a strategic pivot for the lender mortgage insurer.